Short-Term mortality risk of serum potassium levels in acute heart failure following myocardial infarction

European Heart Journal - Cardiovascular Pharmacotherapy

Volumn 1, Issue 4, 2015, Pages 245-251

  Krogager, Maria Lukács ^a   Eggers Kaas, Lotti ^a   Aasbjerg, Kristian ^a   Mortensen, Rikke Nørmark ^a   Køber, Lars ^b   Gislason, Gunnar ^c,d   Torp Pedersen, Christian ^a   Søgaard, Peter ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b Heart Center   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Heart failure after myocardial infarction; Mortality; Serum potassium

Indexed keywords

LOOP DIURETIC AGENT; POTASSIUM;

ACUTE HEART FAILURE; AGED; ALL CAUSE MORTALITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW; SHORT TERM SURVIVAL;

EID: 84988895946     PISSN: 20556837     EISSN: 20556845     Source Type: Journal    
DOI: 10.1093/ehjcvp/pvv026     Document Type: Review

References (34)

1. Whelton PK, Watson AJ. Diuretic-induced hypokalemia and cardiac arrhythmias. Am J Cardiol 1986;58:5A-10A.
2. Podrid PJ. Potassium and ventricular arrhytmias. Am J Cardiol 1990;65:12E-33E.
3. Bielecka-Dabrowa A, Mikhailidis DP, Jones L, Rysz J, Aronow WS, Banach M. The meaning of hypokalemia in heart failure. Int J Cardiol 2012;158:12-17.
4. Bielecka-Dabrowa A, Rysz J, Mikhailidis DP, Banach M. What is the risk of hyperkalaemia in heart failure? Expert Opin Pharmacother 2011;12:2329-2338.
5. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004;43:155-161.
6. Wang YC, Chen SL, Deng NY, Wang Y. Network predicting drug's anatomical therapeutic chemical code. Bioinformatics 2013;29:1317-1324.
7. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011;11:83.
8. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-1139.
9. Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, Sørensen R, Folke F, Gadsbøll N, Rasmussen S, Køber L, Madsen M, Torp- Pedersen C. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation 2007;116:737-744.
10. Andersson C, Norgaard ML, Hansen PR, Fosbol EL, Schmiegelow M, Weeke P, Olesen JB, Raunsø J, Jørgensen CH, Vaag A, Køber L, Torp-Pedersen C, Gislason GH. Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: A nationwide cohort study. Eur J Heart Fail 2010;12:1333-1338.
11. Kumler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Kober L, Torp-Pedersen C. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008;10:658-660.
12. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006;97:1759-1764.
13. Spencer FA, Meyer TE, Goldberg RJ, Yarzebski J, Hatton M, Lessard D, Gore JM. Twenty year trends (1975-1995) in the incidence, in-hospital and long-Term death rates associated with heart failure complicating acute myocardial infarction: A community-wide perspective. J Am Coll Cardiol 1999;34:1378-1387.
14. Hellermann JP, Goraya TY, Jacobsen SJ, Weston SA, Reeder GS, Gersh BJ, Redfield MM, Rodeheffer RJ, Yawn BP, Roger VL. Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 2003;157: 1101-1107.
15. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 2009;53:13-20.
16. Kelly DJ, Gershlick T, Witzenbichler B, Guagliumi G, Fahy M, Dangas G, Mehran R, Stone GW. Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial. Am Heart J 2011;162:663-670.
17. van Deursen VM, Urso R, Laroche C, Damman K, Dahlstrom U, Tavazzi L, Maggioni AP, Voors AA. Co-morbidities in patients with heart failure: An analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014;16:103-111.
18. Martensson A, Rustad P, Lund H, Ossowicki H. Creatininium reference intervals for corrected methods. Scand J Clin Lab Invest 2004;64:439-441.
19. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, Hyltoft Petersen P, Simonsson P, Steensland H, Uldall A. The Nordic Reference Interval Project 2000: Recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271-284.
20. Carlsson L, Lind L, Larsson A. Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 2010;56:259-265.
21. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:d124.
22. Studies of left ventricular dysfunction (SOLVD)-rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990;66:315-322.
23. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325:293-302.
24. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-691.
25. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999;100: 1311-1315.
26. Pitt B, RemmeW, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gaitlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
27. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
28. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, BaigW, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdomheart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998;98:1510-1516.
29. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 2007;28:1334-1343.
30. Velavan P, Khan NK, Goode K, Rigby AS, Loh PH, Komajda M, Follath F, Swedberg K, Madeira H, Cleland JG. Predictors of short term mortality in heart failure- insights from the Euro Heart Failure survey. Int J Cardiol 2010;138:63-69.
31. Kjeldsen K. Hypokalemia and sudden cardiac death. Exp Clin Cardiol 2010;15: E96-e99.
32. Krijthe BP, Heeringa J, Kors JA, Hofman A, Franco OH, Witteman JC, Stricker BH. Serum potassium levels and the risk of atrial fibrillation: The Rotterdam Study. Int J Cardiol 2013;168:5411-5415.
33. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Wijngaarden DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-Analysis. J Am Coll Cardiol 2008;52:818-827.
34. Pourmoghaddas A, Shemirani H, Garakyaraghi M. Association of serum potassium level with ventricular tachycardia after acute myocardial infarction. ARYA Atheroscler 2012;8:79-81.